Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00457977 · ClinicalTrials.gov registry record · Phase 3
Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease
A Phase 3 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 3
- Development phase
- 181
- Enrollment target
NCT00457977 is a Phase 3 study that has completed, run by University of Minnesota. The registered enrollment target is 181 participants.
The verdict
NCT00457977, a Phase 3 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 181 participants
- Enrollment target
Study Summary
Pneumococcal disease is a serious bacterial infection that can affect different parts of the body, including the lungs. People with chronic illnesses, such as chronic obstructive pulmonary disease (COPD), have a greater risk of developing pneumonia and meningitis as a result of pneumococcal disease. This study will compare the immune response to two types of pneumococcal vaccines in adults with COPD.
Interventions
- BIOLOGICAL Pneumovax (PPSV23)
- BIOLOGICAL Prevnar (PCV7)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2007-03 |
| Est. Completion | 2011-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00457977
The ClinicalTrials.gov registry entry for NCT00457977 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pneumovax (PPSV23) is the first listed.
NCT00457977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00457977 about?
NCT00457977 is a clinical study titled "Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease". Pneumococcal disease is a serious bacterial infection that can affect different parts of the body, including the lungs. People with chronic illnesses, such as chronic obstructive pulmonary disease (COPD), have a greater risk of developing pneumonia and meningitis as a result of pneumococcal disease....
What is the current status of trial NCT00457977?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 181 participants. The study started on 2007-03. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00457977?
The interventions under investigation include: Pneumovax (PPSV23) (BIOLOGICAL), Prevnar (PCV7) (BIOLOGICAL).
Who is sponsoring clinical trial NCT00457977?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.